Stage IB Non-Small Cell Lung Carcinoma AJCC v7 (DBCOND0090364)

Identifiers

Synonyms

Stage IB Lung Non-Small Cell Carcinoma AJCC v7

Associated Data

Indicated Drugs and Targets

Not Available

Clinical Trials

Identifier	Title	Drug(s)	Purpose	Phase	Status
NCT00324805	Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-small Cell Lung Cancer That Was Removed By Surgery	Bevacizumab Chloride ion Cisplatin Docetaxel Gemcitabine Pemetrexed Platinum Vinorelbine	treatment	3	active_not_recruiting
NCT02193282	Erlotinib Hydrochloride in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Completely Removed by Surgery (An ALCHEMIST Treatment Trial)	Erlotinib	treatment	3	active_not_recruiting
NCT02194738	Genetic Testing in Screening Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been or Will Be Removed by Surgery (The ALCHEMIST Screening Trial)	Carboplatin Chloride ion Cisplatin Crizotinib Erlotinib Gemcitabine Nivolumab Paclitaxel Pembrolizumab Pemetrexed Platinum Tyrosine	screening	Not Available	recruiting
NCT02595944	Nivolumab After Surgery and Chemotherapy in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer (An ALCHEMIST Treatment Trial)	Nivolumab	treatment	3	active_not_recruiting
NCT00254384	Docetaxel, Cisplatin, and Erlotinib Hydrochloride in Treating Patients With Stage I-III Non-small Cell Lung Cancer Following Surgery	Chloride ion Cisplatin Docetaxel Erlotinib Platinum	treatment	1	completed
NCT03158129	Nivolumab With or Without Ipilimumab or Chemotherapy in Treating Patients With Previously Untreated Stage I-IIIA Non-small Cell Lung Cancer	Carboplatin Chloride ion Cisplatin Docetaxel Ipilimumab Nivolumab Pemetrexed Platinum	treatment	2	active_not_recruiting
NCT03493789	Fludeoxyglucose F-18-PET in Planning Lung Cancer Radiation Therapy	Fludeoxyglucose (18F) Fluorine F-18	diagnostic	1	completed
NCT02225405	Cisplatin, Docetaxel, and Nintedanib Before Surgery in Treating Patients With Previously Untreated Stage IB-IIIA Non-small Cell Lung Cancer	Chloride ion Cisplatin Docetaxel Nintedanib Platinum Tyrosine	treatment	1	completed
NCT03348748	Stereotactic Body Radiation Therapy Followed by Surgery in Treating Patients With Stage I-IIIA Non-small Cell Lung Cancer	No drug interventions	treatment	0	active_not_recruiting
NCT02201992	Crizotinib in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Removed by Surgery and ALK Fusion Mutations (An ALCHEMIST Treatment Trial)	Crizotinib Tyrosine	treatment	3	recruiting